Some unresolved issues with botulinum toxin

被引：0

作者：

Barry M. Guyer

机构：

[1] DuoMed Limited,

[2] Medical Affairs Consultancy,undefined

[3] 63 Moberly Road,undefined

[4] Salisbury,undefined

[5] Wilts,undefined

[6] SP1 3BX,undefined

[7] UK,undefined

[8] Tel.: ++44-1722-338259,undefined

[9] Fax: ++44-1722-338259,undefined

[10] e-mail: bguyer@duomed.co.uk,undefined

来源：

Journal of Neurology | 2001年 / 248卷 / Suppl 1期

关键词：

Key words Botulinum toxin; Assay; Dilution; Pharmacodynamics; Antibodies;

D O I：

10.1007/PL00007811

中图分类号：

学科分类号：

摘要：

Issues concerning botulinum toxin still need resolution in the laboratory and clinic. Assay nomenclature is unsatisfactory and attempts to establish common units and / or equivalents are misguided and dangerous. Optimum toxin concentrations for most indications are unknown. Loss of response is too readily ascribed to antibody formation. New therapeutic indications for toxin raise the possibility of additional mechanisms of action.

引用

页码：I11 / I13

共 50 条

[41] SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E
Bak, Nicola
Rajagopal, Shalini
Stickings, Paul
Sesardic, Dorothea
TOXINS, 2017, 9 (07)
[42] Evaluation of concentrations of botulinum toxin A for the treatment of hemifacial spasm: a randomized double-blind crossover trial
Li, Y. J.
Huang, Y.
Ding, Q.
Gu, Z. H.
Pan, X. L.
GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 1136 - 1144
[43] Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study
Garcia Ruiz, Pedro J.
Martinez Castrillo, Juan Carlos
Burguera, Juan A.
Campos, Victor
Castro, Alfonso
Cancho, Esther
Chacon, Jose
Hernandez Vara, Jaime
Lopez del Val, Javier
Lopez Garcia, Elena
Miquel, Francesc
Sanz, Pilar
Vela, Lydia
JOURNAL OF NEUROLOGY, 2011, 258 (06) : 1055 - 1057
[44] The EDB test - A clinical test for the detection of antibodies to botulinum toxin type A
Kessler, KR
Benecke, R
MOVEMENT DISORDERS, 1997, 12 (01) : 95 - 99
[45] Botulinum Toxin Testing on Animals is Still a Europe-Wide Issue
Taylor, Katy
Gericke, Corina
Alvarez, Laura Rego
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2019, 36 (01) : 81 - 90
[46] Evidence-based medicine in botulinum toxin therapy for cervical dystonia
Andrés O. Ceballos-Baumann
Journal of Neurology, 2001, 248 (Suppl 1) : I14 - I20
[47] Proof of botulinum toxin antibodies with the Extensor-digitorum-brevis Test
Bachhuber, A.
Wagner, A.
Reichel, G.
Doberenz, M.
Stenner, A.
Hermann, W.
NERVENARZT, 2008, 79 (08): : 908 - 911
[48] Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option
Janbernd Kirschner
Steffen Berweck
Volker Mall
Rudolf Korinthenberg
Florian Heinen
Journal of Neurology, 2001, 248 (Suppl 1) : I28 - I30
[49] Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A
Lin, Lucy
Olson, Margaret E.
Sugane, Takashi
Turner, Lewis D.
Tararina, Margarita A.
Nielsen, Alexander L.
Kurbanov, Elbek K.
Pellett, Sabine
Johnson, Eric A.
Cohen, Seth M.
Allen, Karen N.
Janda, Kim D.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11100 - 11120
[50] Botulinum toxin: evidence-based medicine criteria in rare indications
Wolfgang H. Jost
André Kohl
Journal of Neurology, 2001, 248 (Suppl 1) : I39 - I44

← 1 2 3 4 5 →